NEW YORK (GenomeWeb) – Bio-Techne has licensed rights to a protein synthesis technology developed by the Medical Research Council Laboratory of Molecular Biology.
MRC Technology, the tech transfer organization for the UK's MRC, said that it has licensed to Bio-Techne the Genetically encoded Orthogonal Protection and Activated Ligation (GOPAL) technology, which enables the site-specific isopeptide bonds between proteins. The license enables the Minneapolis, Minn.-based life science research tools firm to develop reagent products using GOPAL.
According to MRC, the technology will first be applied to developing ubiquitin dimmers, with the potential for development of trimers and tetramers. It added that Bio-Techne's Boston Biochem company will investigate the use of GOPAL in "introducing post-translational modifications into proteins for structural and functional studies."
Financial and other terms of the license were not disclosed.